The in vitro initiation of polypeptides on endogenous polyribosomes has been studied in extracts from HeLa cells. Regulation of the rate of initiation of polypeptides can be examined. In these experiments an assay using [uSjfMet-tRNAiMet has been developed, and the system further characterized.
The control of the translation of a relatively stable population of messenger RNA molecules appears to be a significant aspect of regulation of protein synthesis in mammalian cells. Several lines of experimentation suggest that an important site of control is the process of initiation (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) . In exponentially growing HeLa cells, it has been possible to induce enhanced rates of initiation in vivo (2, 10) by exposing cells to a period of decreased protein synthesis caused by elevated temperature, treatment with cycloheximide, or starvation for an essential amino acid. We shall refer to cells that have been exposed to conditions inhibiting protein synthesis as "stressed." We shall show that stressing cells results directly in activating a soluble factor in the cytoplasm which leads to enhanced rates of initiation.
A second distinct phenomenon is the gradual loss of the capacity of polyribosomes to initiate polypeptides both in vivo and in vitro when new RNA synthesis is blocked by actinomycin. The lesion occurs prior to the loss of significant amounts of mRNA and appears due to a block by the drug of the appearance of a component necessary for proper initiation on polyribosomes. Furthermore,-the loss of this factor in actinomycin during "stress" prevents polyribosomes from responding to the activated soluble fraction. We believe this ribosome-associated factor can be demonstrated only on endogenous polyribosomes from cells with active RNA metabolism (Reichman, Goldstein, and Penman, manuscript in preparation).
In order to study the biochemical events involved in the cellular control of the initiation of translation, an in vitro system reflecting the in vivo state was needed. Recently, such a system has been developed using HeLa cells (11 ,000 cpm are added to start the incubation, which is carried out for 10 mm at 250. When initiation was to be inhibited specifically, ATA (aurintricarboxylic acid) at a concentration of 100 uM was used and the ATA insensitive incorporation was subtracted from the total. The reactions were terminated by the addition of 0.1 N NaOH and incubated at 370 for 5 min. Ten percent trichloroacetic acid containing sodium pyrophosphate and casamino acids was then added. The precipitate was collected by centrifugation, dissolved in 0.1 N NaOH, reprecipitated with trichloroacetic acid, and collected on Millipore filters. The filters were assayed for radioactivity by liquid scintillation counting. Protein determinations were by the procedure of Lowry et al. (14) . Each reaction contained extract from 2 X 107 cells.
Preparation of [85S]fMet-tRNAfMet. RNA was prepared from beef liver by extraction with phenol (15) . High-molecular-weight RNA was removed by precipitation with 2 M NaCl. The soluble RNA was partially purified on a benzoylated DEAE-cellulose column in order to separate the two methionine tRNA peaks (16) . The partially purified tRNAfMet was acylated with [35S]methionine and formylated with a crude Escherichia coli synthetase preparation according to RajBhandary and Ghosh (17) . The final product was used at 10-15,000 cpm/ug of tRNA.
HeLa tRNA was prepared by extracting with phenol the cell supernatant from a 150,000 X g centrifugation. The total tRNA was acylated and formylated with the E. coli enzyme preparation as described above. Any unformylated Met-tRNA was deacylated by CUSO4 treatment according to Schofield and Zamecnik (18) , leaving [E5S]fMet-tRNAfMet that was more than 90% formylated. The tRNA-was used at 40,000 cpm/,ug of tRNA.
RESULTS
In this report, we first show that the assay actually measured polypeptide initiation on endogenous polyribosomes. We then demonstrate that the initiation rate in the total extract can be manipulated by pretreating the cells. The alterations in in vitro activity follow those previously seen in vivo. Finally, we show the results of fractionating the total extract into polyribosomes and supernatant.
It is worth emphasizing that the system used here differs from many others. Polypeptide initiation on endogenous polyribosomes is measured in an extract derived from growing cells. We believe this approach shows aspects of protein synthesis regulation not seen in studies on endogenous polyribosomes from nongrowing cells (reticulocytes) or in extracts from growing cells where initiation is measured on exogenous mRNA.
In a previous report, it was shown that N-terminal amino acids are labeled in these extracts only if methionine is the radioactive donor (11). This labeling was completely suppressed by concentrations of pactamycin that only had a small effect on labeling internal amino acids.
The advantages of using labeled, formylated Met-tRNAfMet to measure initiation are several. The formylated form of the tRNA should be more resistant to deacylation during the in vitro incubation. Also, this procedure is considerably simpler than the lengthy Edman degradation techniques for determining the amount of initiation. In the initial experiments, tRNAf Met was first purified on benzoylated DEAE-cellulose and then charged and formylated with an E. coli enzyme preparation. Later, a simplified technique was adopted in which total tRNA was charged and formylated, and then all nonformylated Met-tRNAs were selectively deacylated in copper sulfate (18) . Both methods of preparing radioactive tRNA give essentially the same results.
The results in Fig. 1 and Table 1 show that the formylated Met-tRNAf Met derived from beef liver enters only into a reaction which is inhibited by ATA, a selective inhibitor of initiation. In Fig. 1 , the inhibition by ATA of incorporation from fMet-tRNAfMet is compared to that of the total incorporation of free methionine. As shown previously, the free methionine enters principally into internal positions. The incorporation from fMet-tRNAfMet is severely inhibited by the ATA, while total incorporation is relatively insensitive. The small amount of methionine radioactivity incorporated in high concentrations of ATA is believed due to a contamination of this preparation with charged Met-tRNAmMet. Later experiments in which the unformylated tRNAs had been selectively deacylated gave background incorporation in the presence of ATA which was essentially negligible (approximately 100 cpm).
Thus, the incorporation from fMet-tRNAfMet appears to be exclusively due to the initiation of new polypeptides. Previous evidence from both in vivo studies and in vitro ability to initiate protein synthesis has indicated that some metabolic activity involving RNA is necessary to maintain proper initiation rates in HeLa cells. This process is inhibited by actinomycin (2, 10, 11) . When this phenomenon was examined in detail in in vivo experiments, it was found that the actinomycin concentration required for half-maximum effect was 0.1-0.2 ,g/ml. This was true for (1) actinomycin-induced decay of protein synthesis, (2) response to the lesion introduced when cells are incubated at the supraoptimal temperature of 420, and (3) inhibition of induction by cycloheximide of protection against the lesion at 420. The data in Fig. 3 show that actinomycin added to cells during the period of prestress inhibits the development of an enhanced rate of initiation in vitro. The dose response to the drug is similar to that found in the in vivo experiments. This suggests that the in vitro measurements reflect the metabolic response of the intact cell. The dependence of initiation on the Mg++ concentration has been examined for prestressed and control lysates (Fig. 4) . A clear difference in behavior of the two systems is apparent. This different Mg++ dependence suggests an alteration in the initiation system and shows the importance of optimizing the magnesium concentration for stimulation rather than simply for initiation. Unfortunately, the lysates described here have proven to be exceedingly unstable. Activity is lost even at 40 with half-life of about 1 hr. This precludes, for the present, elaborate fractionation procedures. However, a quantitative separation of ribosomes and subunits from soluble components is possible by high-speed centrifugation in small centrifuge tubes. Lysates from control and cycloheximide-prestressed cells were reconstituted from their component supernatant and ribosomal fractions. The data in Table 3 show that reconstituted lysates exhibit the same degree of stimulation of in vitro initiation as do nonfractionated lysates.
Much greater insight is obtained when the supernatant and polyribosome fractions from the two sources are mixed. Prestressing cells with cycloheximide results in an enhanced capacity to initiate protein synthesis. This activity is largely found in the supernatant, but a variable portion is found in the ribosome fraction. Thus, the ribosomal fraction from prestressed cells will sometimes show an enhancement of initiation when mixed with supernatant from control cells. In such cases, the enhancing activity in the prestressed supernatant is correspondingly reduced. The behavior is as though a fixed amount of enhancing activity is induced, but its partition between ribosomes and supernatant can vary. The source of this variability is not known at present, and is not due to any of the more obvious variables, such as ionic conditions. In most experiments, the major portion of stimulatory activity presence of cycloheximide, exactly the same results are obtained, for the ribosomes at least, when actinomycin is used alone.
Actinomycin does not prevent the appearance of the stimulated soluble activity. Rather, the supernatant fraction from cycloheximide-actinomycin-treated cells consistently appears superstimulated. We conclude that the appearance of the stimulatory activity is due to the inhibition of protein synthesis and does not require new RNA. The superstimulation is at present not understood and conceivably represents still another process.
The ribosomes from actinomycin-treated cells are somewhat less active than those from control cells when exposed to a control supernatant. This effect is magnified after longer treatments with actinomycin, as will be reported elsewhere. Here, the polyribosomes from actinomycin-treated cells appear to have just begun losing their normal initiating capacity.
The most striking observation is the inability of the ribosomes from actinomycin-treated cells to respond to the stimulated supernatants. Thus the block of RNA synthesis results in ribosomes gradually losing the ability to respond to stimulated supernatants. We propose that a factor, which is strictly associated with polyribosomes, is gradually lost during exposure to actinomycin. We further suggest that the unstable component of this factor is probably RNA, since its replenishment is blocked by actinomycin and not by cycloheximide. In all cases the mRNA in the polyribosomes appears normal. We term the putative factor an "activator," since its presence is necessary for polyribosome function. The polyribosomeassociated component has no obvious counterpart in systems that initiate on exogenous mRNA. DISCUSSION
In these experiments, we study the initiation of polypeptide synthesis on the endogenous polyribosomes of a cell synthesizing a wide spectrum of proteins, using a simplified assay based on [85S ]fMet-tRNAfMet. The system can show in vitro the alterations in rates of polypeptide initiation produced in vivo. The factorology of mammalian protein synthesis is already complex and it is with great reluctance that we suggest additional components that regulate the initiation of translation. However, these results and others to be reported elsewhere lead to a seemingly inescapable conclusion: i.e., at least two controlling elements are present in this system which have no apparent counterpart in the known factors that have been described to date.
1 2. The most significant finding reported here concerns the polyribosome-associated factor. This is a component of the endogenous protein synthetic system that has no counterpart in exogenous message systems. There appears to be a factor associated only with endogenous polyribosomes that is necessary for initiation. This polysome factor decays when actinomycin is administered to cells but is apparently unaffected by cycloheximide. The disappearance of this factor is first seen in the failure of polyribosomes from actinomycin-treated cells to respond to stimulated supernatants. Possibly the polysome factor becomes rate-limiting and the additional activity in the supernatant cannot be manifested. In a subsequent report, we will show that poliovirus infection in the presence of actinomycin leads to completely nonfunctional endogenous message. However, this same message, when extracted and fed back to the same extracts, functions as well as any other exogenous mRNA. Failure of endogenous message to function normally in cells in which the polyribosome factor has apparently decayed distinguishes protein synthesis on endogenous polyribosomes from that measured on exogenous mRNA.
There is a candidate for such a regulatory RNA. A 7S RNA has been found both on host polyribosomes and associated with the RNA of oncornoviruses (19) .
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